David Ge work email
- Valid
- Valid
David Ge personal email
Dream builder. From $0 to multi-million. My journey:• [Stage 3. 2017- ] • A liquid biopsy technology - a best-in-class, independently validated Apostle MiniMax cfDNA isolation technology, featured in Science, 2019;364(6441):696, New Products. Also applied in the Apostle Nucleic Acid Isolation Automation System. Served over 20 million people. • Apostle Diagnostics - a CLIA Certified, CAP Accredited, and California State Licensed Clinical Laboratory. Trusted by hundreds of thousands. Bay Area's No. 1 chosen COVID-19 travel test center, serving over 25 countries.• [Stage 2. 2011-2016] A cure - participated in the clinical development of Sofosbuvir, a multi-billion drug that cures hepatitis C; led the phylogenomic analyses • [Stage 1. 2006-2011] A genomic diagnostic - invented genomic diagnostic products: Quest AccuType® IL28B，LabCorp 480630. Publication: Nature 2009:461(7262),399Bioinformatics and genomics enthusiast• BioSpace “Top 20 Life Science Startups to Watch 2018”• A Stanford University StartX company (acceptance 8%-10%)• Featured in: Cell-Free DNA Isolation Kit. Science. 17 May 2019:Vol. 364, Issue 6441, pp. 696. DOI: 10.1126/science.364.6441.696-a. (New Products section)• Apostle MiniMax and MiniGenomics Technologies with Automated Isolation System serving over 20 million people. • Apostle Diagnostics - a CLIA-certified, CAP-accredited, California-licensed clinical lab. Served over 100,000 people.• U.S. Citizen through federal "Outstanding Professors and Researchers"• "Top 50 Most Influential People in Big Data" in 2015, named by U.K. Phacilitate• “Rising Stars” in 2009, named by the U.S. Genome Technology magazine• Headed the Bioinformatics Department of Gilead Sciences• Faculty member of Duke University School of Medicine• 5 articles in Nature and 1 in Science (2 first-authored); 20,000+ citations. • Work referenced by the U.S. FDA Guidelines for Industry: Enrichment Strategies; Chronic HCV infection
-
Ceo & FounderApostle Inc 2017 - PresentPleasanton, California, Us• Innovations for mankind. Serving public health and life science. Products served over 20 million people.• A best-in-class cfDNA isolation technology, used in a liquid biopsy. Independently validated.• BioSpace Top 20 Life Science Startups to Watch (2018)• A Stanford University StartX company (2018)• Apostle Diagnostics is a CLIA Certified, CAP Accredited, and California State Licensed Clinical Laboratory. -
PresidentSimcere Pharma Bsk 2016 - 2017• A sister company of Simcere Pharmaceutical Group, focusing on innovation, incubating, investing and licensing in biomedical sciences• Invested in 3 of the "50 Smartest Companies 2016 - MIT Technology Review"• Invested in 2 of the 3 European Biotech Unicorns in 2016• Founded Simcere Diagnostics in 2017 -
Director, Bioinformatics; Head Of BioinformaticsGilead Sciences 2011 - 2016Foster City, Ca, Us• Head of Bioinformatics Department• Provide leadership to bioinformatics to enable the company to meet its regulatory, scientific and business objectives• Provide strategic input to R&D infrastructure, process, hardware and software platforms for next-generation sequencing studies, genome-wide association studies and other genomic technologies• Provided genomic platforms and analytical supports for critical programs: Sovaldi ® (Sofosbuvir 400mg) NDA• Deployed next-generation sequencing pipeline• Deployed cloud-based massive parallel computing and big data facility -
Assistant Professor Of Biostatistics And Bioinformatics; Assistant Professor In MedicineDuke University 2008 - 2011Durham, North Carolina, UsFocuses• Genomic platform implementation and application: Next-Generation Sequencing studies (NGS) and Genome-Wide Association Studies (GWAS)• Bioinformatics methodology research; Pharmacogenomics; -omics platform/databases/ knowledgebase implementation, integration and application; Complex data visualization• Genomic research for dissecting genetic contributors to human complex traits and their interactions• Clinical trial; Precision Medicine; Translational MedicineKey Achievements• Inventor of genomic diagnostic patents in precision medicine; successfully translated into products: Quest AccuType® IL28B，LabCorp 480630• Contributed to the U.S. FDA guidelines for industry; • Biostatistical and bioinformatic software development: SVA, WGAViewer, SNPExpress, PipeCMD• Published 5 articles in Nature and 1 in Science; work in total receiving over 18,000 citations.
David Ge Skills
David Ge Education Details
-
Duke UniversityBioinformatics -
Peking Union Medical CollegeBiostatistics And Genetic Epidemiology/Bioinformatics
-
Fudan UniversityPreventive Medicine
Frequently Asked Questions about David Ge
What company does David Ge work for?
David Ge works for Apostle Inc
What is David Ge's role at the current company?
David Ge's current role is CEO at Apostle Bio.
What is David Ge's email address?
David Ge's email address is dg****@****bio.com
What schools did David Ge attend?
David Ge attended Duke University, Peking Union Medical College, Fudan University.
What skills is David Ge known for?
David Ge has skills like Bioinformatics, Genomics, Biomarkers, Biotechnology, Pharmaceutical Industry, Biostatistics, Genetics, Molecular Biology, Drug Discovery, Clinical Trials, Biomarker Discovery, Computational Biology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial